<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Good News on Alzheimer&#8217;s Funding</title>
	<atom:link href="http://alzheimersadvocacy.com/2007/04/05/good-news-on-alzheimers-funding/feed/" rel="self" type="application/rss+xml" />
	<link>http://alzheimersadvocacy.com/2007/04/05/good-news-on-alzheimers-funding/</link>
	<description>Support for Alzheimer's Patient Caregivers</description>
	<lastBuildDate>Fri, 10 Jun 2011 12:54:13 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
	<item>
		<title>By: admin</title>
		<link>http://alzheimersadvocacy.com/2007/04/05/good-news-on-alzheimers-funding/comment-page-1/#comment-4328</link>
		<dc:creator>admin</dc:creator>
		<pubDate>Wed, 09 May 2007 15:20:46 +0000</pubDate>
		<guid isPermaLink="false">http://alzheimersadvocacy.com/2007/04/05/good-news-on-alzheimers-funding/#comment-4328</guid>
		<description>Tony,
Thanks for the news. 
Katelyn</description>
		<content:encoded><![CDATA[<p>Tony,<br />
Thanks for the news.<br />
Katelyn</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Tony</title>
		<link>http://alzheimersadvocacy.com/2007/04/05/good-news-on-alzheimers-funding/comment-page-1/#comment-4208</link>
		<dc:creator>Tony</dc:creator>
		<pubDate>Tue, 08 May 2007 16:06:01 +0000</pubDate>
		<guid isPermaLink="false">http://alzheimersadvocacy.com/2007/04/05/good-news-on-alzheimers-funding/#comment-4208</guid>
		<description>I wanted to alert you that there&#039;s a new study that sheds light on the economies of Alzheimerâ€™s drug development and treatment.

The study was sponsored by ACT-AD, a coalition of 49 national organizations representing patients, providers, caregivers, consumers, older Americans, researchers and employers and shows that the U.S. could save trillions of dollars by 2050 if critical Alzheimer&#039;s treatments were available. 

Feel free to contact me for more information or if you&#039;d like to receive a copy of the report. 

Tony Obregon
tony_obregon@cohnwolfe.com</description>
		<content:encoded><![CDATA[<p>I wanted to alert you that there&#8217;s a new study that sheds light on the economies of Alzheimerâ€™s drug development and treatment.</p>
<p>The study was sponsored by ACT-AD, a coalition of 49 national organizations representing patients, providers, caregivers, consumers, older Americans, researchers and employers and shows that the U.S. could save trillions of dollars by 2050 if critical Alzheimer&#8217;s treatments were available. </p>
<p>Feel free to contact me for more information or if you&#8217;d like to receive a copy of the report. </p>
<p>Tony Obregon<br />
<a href="mailto:tony_obregon@cohnwolfe.com">tony_obregon@cohnwolfe.com</a></p>
]]></content:encoded>
	</item>
</channel>
</rss>

